Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions for animal identification, monitoring and traceability; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Merck & Company Inc.

Merck & Company ( ($MRK) ) has shared an announcement. On May 22, 2026, Merck & Co., Inc. completed an underwritten public offering of multiple tra...

Merck Completes $6 Billion Multi-Tranche Senior Notes Offering

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Merck & Company (MRK) and BioInvent International AB...

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and BioInvent International AB (OtherBOVNF)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Regeneron (REGN) and Merck & Company (MRK) with bull...

Analysts Are Bullish on These Healthcare Stocks: Regeneron (REGN), Merck & Company (MRK)

Exchange-traded funds (ETFs) remain a popular investment choice as investors seek diversification, lower costs, and exposure to fast-growing sector...

Best ETFs to Invest In, According to AI Analyst, 5/21/2026

In a report released today, from Jefferies maintained a Buy rating on Merck & Company, with a price target of $138.00. In addition to Jefferies, Me...

Jefferies Reaffirms Their Buy Rating on Merck & Company (MRK)

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Hold rating on Merck KGaA, with a price target of €125.00. According t...

Merck KGaA (0O14) Receives a Hold from Deutsche Bank

Exchange-traded funds (ETFs) remain a popular choice for investors seeking diversified exposure, lower risk, and long-term growth potential. From A...

Best ETFs to Invest In, According to AI Analyst, 5/14/2026

UBS analyst Matthew Weston maintained a Buy rating on Merck KGaA today and set a price target of €150.00. According to TipRanks, Weston is ranked #...

Merck KGaA (0O14) Receives a Buy from UBS

J.P. Morgan analyst Richard Vosser maintained a Buy rating on Merck KGaA today and set a price target of €150.00. According to TipRanks, Vosser is ...

J.P. Morgan Sticks to Their Buy Rating for Merck KGaA (0O14)

Marker Therapeutics ( ($MRKR) ) has shared an announcement. At its May 1, 2026 annual meeting, Marker Therapeutics’ shareholders re-elected all fiv...

Marker Therapeutics Shareholders Approve Governance and Capital Changes

Guggenheim analyst Vamil Divan reiterated a Buy rating on Merck & Company yesterday and set a price target of $140.00. According to TipRanks, Divan...

Guggenheim Sticks to Their Buy Rating for Merck & Company (MRK)

In a report released today, Evan Seigerman from BMO Capital maintained a Buy rating on Merck & Company, with a price target of $135.00. According t...

BMO Capital Remains a Buy on Merck & Company (MRK)

Scotiabank analyst Louise Chen maintained a Buy rating on Merck & Company on May 1 and set a price target of $136.00. The company’s shares closed l...

Scotiabank Sticks to Its Buy Rating for Merck & Company (MRK)

Kepler Capital analyst David Evans maintained a Buy rating on Merck KGaA on May 1 and set a price target of €152.00. According to TipRanks, Evans i...

Kepler Capital  Reaffirms Their Buy Rating on Merck KGaA (0O14)

Morgan Stanley analyst Terence Flynn maintained a Hold rating on Merck & Company today and set a price target of $112.00. According to TipRanks, Fl...

Morgan Stanley Sticks to Its Hold Rating for Merck & Company (MRK)

In a report released today, Jason Gerberry from Bank of America Securities reiterated a Buy rating on Merck & Company, with a price target of $130....

Bank of America Securities Remains a Buy on Merck & Company (MRK)

Analysts have been eager to weigh in on the Real Estate sector with new ratings on Camden Property (CPT), Newmark Group (NMRK) and LXP Industrial T...

Analysts Offer Insights on Real Estate Companies: Camden Property (CPT), Newmark Group (NMRK) and LXP Industrial Trust (LXP)

Here’s a look at today’s key earnings reports from major publicly traded companies. Stock market investors will undoubtedly be watching closely for...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MRK	$120.41	-1.64%	6.59M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MRK	$120.41	-1.6%	6.59M
3
4
5
6

MRK

MRK

Get Merck & Company Inc. Data in Excel

Get Merck & Company Inc. Data in Excel